JVMCX
Price
$27.30
Change
+$0.17 (+0.63%)
Updated
Jul 3 closing price
Net Assets
22.61B
TSMVX
Price
$28.59
Change
+$0.10 (+0.35%)
Updated
Jul 3 closing price
Net Assets
651.43M
Interact to see
Advertisement

JVMCX vs TSMVX

Header iconJVMCX vs TSMVX Comparison
Open Charts JVMCX vs TSMVXBanner chart's image
JHancock Disciplined Value Mid Cap C
Price$27.30
Change+$0.17 (+0.63%)
VolumeN/A
Net Assets22.61B
Transamerica Small/Mid Cap Value I2
Price$28.59
Change+$0.10 (+0.35%)
VolumeN/A
Net Assets651.43M
JVMCX vs TSMVX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
JVMCX vs. TSMVX commentary
Jul 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JVMCX is a StrongBuy and TSMVX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
JVMCX has more cash in the bank: 22.6B vs. TSMVX (651M). TSMVX pays higher dividends than JVMCX: TSMVX (1.11) vs JVMCX (0.00). JVMCX was incepted earlier than TSMVX: JVMCX (14 years) vs TSMVX (20 years). JVMCX (1.88) is less costly to investors than TSMVX (0.80). JVMCX (47.00) and TSMVX (46.00) have comparable annual turnover. TSMVX has a lower initial minimum investment than JVMCX: TSMVX (0) vs JVMCX (1000). JVMCX annual gain was more profitable for investors over the last year : 1.79 vs. TSMVX (-0.14). JVMCX return over 5 years is better than : 55.49 vs. TSMVX (37.25).
JVMCXTSMVXJVMCX / TSMVX
Total Expense Ratio1.870.80234%
Annual Report Gross Expense Ratio1.880.80235%
Fund Existence14 years20 years-
Gain YTD7.9053.662216%
Front LoadN/AN/A-
Min. Initial Investment10000-
Min. Initial Investment IRAN/AN/A-
Net Assets22.6B651M3,472%
Annual Yield % from dividends0.001.11-
Returns for 1 year1.79-0.14-1,318%
Returns for 3 years20.122.19919%
Returns for 5 years55.4937.25149%
Returns for 10 years35.646.44553%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SMBC58.131.45
+2.56%
Southern Missouri Bancorp
UDR40.800.23
+0.57%
UDR
TR35.470.19
+0.54%
Tootsie Roll Industries Inc
ZNTL1.24N/A
N/A
Zentalis Pharmaceuticals
RSLS2.37-0.05
-2.07%
ReShape Lifesciences Inc.